Journal profile · Medicine-Oncology
Experimental Oncology
ISSN 1812-9269 · Morion LLC
Experimental Oncology: subscription journal; 69 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Experimental Oncology is published by Morion LLC. By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Cancer Cells and Metastasis and Cancer and biochemical research, together about 20.8% of its articles. Its main subfields are Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology9.8%
- Cancer Cells and MetastasisMedicine5.6%
- Cancer and biochemical researchBiochemistry, Genetics and Molecular Biology5.4%
- Lymphoma Diagnosis and TreatmentMedicine5.1%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5%
- Chronic Lymphocytic Leukemia ResearchMedicine5%
- Breast Lesions and CarcinomasMedicine4.7%
- Effects of Radiation ExposureMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Oncology | Q3 | 315/428 | 26th |
| Cancer Research | Q4 | 199/233 | 14th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.4LetPub ·
- SJR 2026-06
- 0.26LetPub ·
- SNIP 2026-06
- 0.23LetPub ·
- h-index
- 23OpenAlex ·
- i10-index
- 130OpenAlex ·
- 2-year mean citedness
- 1.21OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 704 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 32 | 326 |
| 2025 | 69 | 65 | 506 |
| 2024 | 54 | 49 | 521 |
| 2023 | 105 | 86 | 521 |
| 2022 | 16 | 16 | 436 |
| 2021 | 69 | 69 | 460 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Morion LLC
- ISSN
- 1812-9269
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Experimental Oncology
Which databases index Experimental Oncology?
According to LetPub and DOAJ records, Experimental Oncology is indexed in Scopus.
Is Experimental Oncology open access, and what is the APC?
Experimental Oncology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .